ASX:LCT

Living Cell Technologies (LCT) Stock Price, News & Analysis

Today's Range
N/A
50-Day Range
N/A
52-Week Range
N/A
Volume
76,622 shs
Average Volume
N/A
Market Capitalization
N/A
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
LCT stock logo

About Living Cell Technologies Stock (ASX:LCT)

Living Cell Technologies Limited, a biotechnology company, discovers, develops, and commercializes regenerative treatments that use naturally occurring cells to restore functions in Australia and New Zealand. It is developing NTCELL, an alginate-coated capsule, which is in phase IIb clinical trial for the treatment of Parkinson's disease. The company was founded in 1987 and is based in Melbourne, Australia.

LCT Stock News Headlines

Elon’s New Device is About to Shock the World
Using this device you see above… Elon Musk just tested a new type of A.I. that according to Wired Magazine will usher in… “The next step in human evolution.”
Elon’s New Device is About to Shock the World
Using this device you see above… Elon Musk just tested a new type of A.I. that according to Wired Magazine will usher in… “The next step in human evolution.”
Defining a city using cell-phone data
Living Cell Technologies Limited (LVCLF)
See More Headlines
Receive LCT Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Living Cell Technologies and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings
2/19/2019
Today
5/03/2024

Industry, Sector and Symbol

Sector
Medical
Industry
Biotechnology
Sub-Industry
N/A
CIK
N/A
Fax
N/A
Employees
147,000
Year Founded
N/A

Profitability

Net Income
$-2,110,000.00
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
$3,405.00

Miscellaneous

Outstanding Shares
1,640,000,000
Free Float
N/A
Optionable
Not Optionable
Beta
0.48
Metaverse Stocks And Why You Can't Ignore Them Cover

Thinking about investing in Meta, Roblox, or Unity? Click the link to learn what streetwise investors need to know about the metaverse and public markets before making an investment.

Get This Free Report

Key Executives

  • Mr. David Richard Hainsworth (Age 50)
    CEO & Exec. Chairman
    Comp: $40k
  • Mr. Daya Uka
    Chief Financial Officer
  • Dr. Belinda Di Bartolo
    Chief Operations Officer
  • Dr. Carolyn M. Sue A.M. (Age 60)
    B.S., Ph.D., Member of Medical Advisory Board & Chief Medical Officer of NTCELL
    Comp: $50k
  • Mr. Madhukar Bhalla FCIS (Age 64)
    Company Sec.
    Comp: $40k
  • Dr. James A. Mckenna
    Chief Scientific Officer

LCT Stock Analysis - Frequently Asked Questions

How were Living Cell Technologies' earnings last quarter?

Living Cell Technologies Limited (ASX:LCT) released its earnings results on Tuesday, February, 19th. The company reported $0.00 earnings per share for the quarter.

What other stocks do shareholders of Living Cell Technologies own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Living Cell Technologies investors own include eWellness Healthcare (EWLL), Energous (WATT), AllianceBernstein Global High Income Fund (AWF).

This page (ASX:LCT) was last updated on 5/3/2024 by MarketBeat.com Staff

From Our Partners